글로벌 부신피질암 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 부신피질암 치료 시장

부신피질암 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 6%의 CAGR로 성장할 것으로 분석합니다.

부신피질 암은 부신피질에서 암세포가 성장하여 발생하는 희귀 질환으로 정의됩니다. 부신피질은 부신의 바깥층으로, 혈압과 신진대사를 조절하는 호르몬을 생성합니다. 또한 코르티솔과 안드로겐 생성에도 관여합니다. 이러한 호르몬의 과도한 생성은 부신피질암으로 인해 발생합니다. 이 질환은 주로 여성의 얼굴과 몸의 털 증가, 과도한 체중 증가, 고혈압, 복통, 근육 약화, 신체 멍, 남성의 유방 조직 비대와 같은 증상이 특징입니다.

희귀 암의 유병률 증가, 의료비 지출 증가, 부신피질암 치료에 대한 기업의 관심 증가, 부신피질 종양을 식별하기 위한 영상 기술의 발전, 암 치료 센터 수의 급증, 정부 자금 지원 증가, 정부와 민간 기관에서 암에 대한 인식을 확산하기 위한 이니셔티브 증가는 부 신피질암 치료 시장을 확대할 요인입니다.

연구 개발 활동의 증가와 진행 중인 임상 시험은 2021~2028년 예측 기간 동안 부신피질암 치료 시장에 유익한 기회를 제공할 것입니다.

However, high cost of treatment and high risk associated with the local recurrence and metastatic progression are the factors that will hinder the market growth and will further challenge the adrenocortical carcinoma treatment market in the forecast period mentioned above.

This adrenocortical carcinoma treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenocortical carcinoma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Adrenocortical Carcinoma Treatment Market Scope and Market Size

The adrenocortical carcinoma treatment market is segmented on the basis of type, drug type, treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the adrenocortical carcinoma treatment market is segmented into localized adrenocortical carcinoma and metastatic adrenocortical carcinoma.
• On the basis of drug type, the adrenocortical carcinoma treatment market is segmented into tamoxifen, mifepristone, toremifene, spironolactone and others.
• On the basis of treatment, the adrenocortical carcinoma treatment market is segmented into surgery, chemotherapy, targeted therapy, radiation therapy, biologic therapy and others.
• On the basis of diagnosis, the adrenocortical carcinoma treatment market is segmented into MRI, CT scan, PET scan, biopsy and others.
• On the basis of end-users, the adrenocortical carcinoma treatment market is segmented into clinic, hospital and others.

The adrenocortical carcinoma treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Adrenocortical Carcinoma Treatment Market Country Level Analysis

Adrenocortical carcinoma treatment market is analyzed and market size information is provided by the country, type, drug type, treatment, diagnosis, end-users and distribution channel as referenced above.

The countries covered in the adrenocortical carcinoma treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the adrenocortical carcinoma treatment market due to the presence of major key players, growing incidences of adrenocortical carcinoma, high disposable income, and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing healthcare expenditure, rising awareness about the treatment and diagnostic methods of disease, favourable reimbursement scenario and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Adrenocortical carcinoma treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Adrenocortical Carcinoma Treatment Market Share Analysis

Adrenocortical carcinoma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to adrenocortical carcinoma treatment market research.

부신피질암 치료 시장 보고서에 포함된 주요 기업으로는 HRA Pharma, GENERAL ELECTRIC COMPANY, WG Critical Care, LLC, Bristol-Myers Squibb Company, Mylan NV, Pfizer Inc., Fresenius Kabi AG, SinoVision, Hitachi, Ltd., NeuroLogica Corp., DIGIRAD CORPORATION, Merck Sharp & Dohme Corp., EnGeneIC Ltd., Exelixis, Inc., Tempest Therapeutics, Inc., ORPHAGEN PHARMACEUTICALS, Integra LifeSciences, Zimmer Biomet 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-66582